Modulating membrane binding of α-synuclein as a therapeutic strategy.
about
Distinct α-Synuclein strains and implications for heterogeneity among α-Synucleinopathies.Serum amyloid A forms stable oligomers that disrupt vesicles at lysosomal pH and contribute to the pathogenesis of reactive amyloidosis.Rationally Designed Variants of α-Synuclein Illuminate Its Structural Properties in Health and DiseaseGanglioside lipids accelerate α-synuclein amyloid formation
P2860
Modulating membrane binding of α-synuclein as a therapeutic strategy.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Modulating membrane binding of α-synuclein as a therapeutic strategy.
@en
Modulating membrane binding of α-synuclein as a therapeutic strategy.
@nl
type
label
Modulating membrane binding of α-synuclein as a therapeutic strategy.
@en
Modulating membrane binding of α-synuclein as a therapeutic strategy.
@nl
prefLabel
Modulating membrane binding of α-synuclein as a therapeutic strategy.
@en
Modulating membrane binding of α-synuclein as a therapeutic strategy.
@nl
P2860
P356
P1476
Modulating membrane binding of α-synuclein as a therapeutic strategy.
@en
P2093
André Pineda
P2860
P304
P356
10.1073/PNAS.1620159114
P407
P577
2017-01-26T00:00:00Z